Component
Choline
Independent biological entity. Read linked claims for experimental scope and context.
31 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Chronic choline treatment made mutant fibroblast ultrastructure resemble healthy control cells.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/choline-research/31855247.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19", "start_char": 0, "end_char": 1785, "text_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19"}
- experimental_model
- Four individuals, three families; patient-fibroblast transport and rescue
- exposure
- SLC44A1 frameshift genotypes, chronic choline treatment and acute iron challenge
- limitations
- Cell rescue is not a demonstrated clinical treatment. Preserved PC content coexisted with disturbed other lipids and organelles. The linked issue-wide erratum corrected publication year to 2020, not these biological findings (PMID 32333675; doi:10.1093/brain/awaa007).
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human
- plain_language
- Extra choline improved the cell phenotype in this experiment.
- primary_references
- [choline-p31855247] Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/31855247/ DOI: 10.1093/brain/awz376
- tissue_or_cell_type
- Patient fibroblasts; clinical neurodegeneration
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 386–397
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Four individuals, three families; patient-fibroblast transport and rescue · source_derived_draft · unverified_draft
### choline-ctl1-cell-rescue Chronic choline treatment made mutant fibroblast ultrastructure resemble healthy control cells. Condition category: machinery_impairment nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Extra choline improved the cell phenotype in this experiment. organism: Human tissue_or_cell_type: Patient fibroblasts; clinical neurodegeneration experimental_model: Four individuals, three families; patient-fibroblast transport and rescue limitations: Cell rescue is not a demonstrated clinical treatment. Preserved PC content coexisted with disturbed other lipids and organelles. The linked issue-wide erratum corrected publication year to 2020, not these biological findings (PMID 32333675; doi:10.1093/brain/awaa007). exposure: SLC44A1 frameshift genotypes, chronic choline treatment and acute iron challenge evidence_span: {"source_cache": "artifacts/choline-research/31855247.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19", "start_char": 0, "end_char": 1785, "text_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19"} [choline-p31855247] Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/31855247/ DOI: 10.1093/brain/awz376
Complete structured claim and evidenceCholine treatment protected the mutant fibroblasts from acute iron overload.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/choline-research/31855247.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19", "start_char": 0, "end_char": 1785, "text_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19"}
- experimental_model
- Four individuals, three families; patient-fibroblast transport and rescue
- exposure
- SLC44A1 frameshift genotypes, chronic choline treatment and acute iron challenge
- limitations
- Cultured-cell rescue under an acute challenge; does not establish clinical iron tolerance or a general choline–iron dosing rule.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human
- plain_language
- Choline handling and iron-stress resistance met in this cell model.
- primary_references
- [choline-p31855247] Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/31855247/ DOI: 10.1093/brain/awz376
- tissue_or_cell_type
- Patient fibroblasts; clinical neurodegeneration
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 399–410
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Four individuals, three families; patient-fibroblast transport and rescue · source_derived_draft · unverified_draft
### choline-ctl1-iron-rescue Choline treatment protected the mutant fibroblasts from acute iron overload. Condition category: machinery_impairment nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Choline handling and iron-stress resistance met in this cell model. organism: Human tissue_or_cell_type: Patient fibroblasts; clinical neurodegeneration experimental_model: Four individuals, three families; patient-fibroblast transport and rescue limitations: Cultured-cell rescue under an acute challenge; does not establish clinical iron tolerance or a general choline–iron dosing rule. exposure: SLC44A1 frameshift genotypes, chronic choline treatment and acute iron challenge evidence_span: {"source_cache": "artifacts/choline-research/31855247.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19", "start_char": 0, "end_char": 1785, "text_sha256": "34cbef18c0e83c0bcd06954a1d81d7329825171b5ecac31f8ea19b2457543f19"} [choline-p31855247] Choline transporter-like 1 deficiency causes a new type of childhood-onset neurodegeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/31855247/ DOI: 10.1093/brain/awz376
Complete structured claim and evidenceIn nonpregnant MTHFR rs1801133 carriers receiving 930 mg choline/day, the betaine-d9:PC-d9 enrichment ratio was 0.87, matching noncarriers receiving 480 mg/day (0.87); noncarriers receiving 930 mg/day had a ratio of 1.0.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Choline modifies a folate-genotype-associated phenotype.
- experimental_model
- Choline feeding and isotope tracing in women across reproductive states.
- exposure
- 480 versus 930 mg/day; recommended folate intake
- limitations
- The matched reference is noncarriers at 480 mg/day, not noncarriers at the same 930 mg/day; subgroup result, not universal restoration or dosing advice.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Higher intake brought carriers to the lower-intake noncarrier reference value.
- primary_references
- [ganz-2016] Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis (2016). https://pubmed.ncbi.nlm.nih.gov/27342765/ DOI: 10.1096/fj.201500138rr
- tissue_or_cell_type
- Plasma tracer metabolites
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 743–754
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Choline feeding and isotope tracing in women across reproductive states. · source_derived_draft · unverified_draft
### folate-methyl-choline-intake-variant In nonpregnant MTHFR rs1801133 carriers receiving 930 mg choline/day, the betaine-d9:PC-d9 enrichment ratio was 0.87, matching noncarriers receiving 480 mg/day (0.87); noncarriers receiving 930 mg/day had a ratio of 1.0. Condition category: machinery_impairment nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Higher intake brought carriers to the lower-intake noncarrier reference value. organism: Homo sapiens tissue_or_cell_type: Plasma tracer metabolites experimental_model: Choline feeding and isotope tracing in women across reproductive states. limitations: The matched reference is noncarriers at 480 mg/day, not noncarriers at the same 930 mg/day; subgroup result, not universal restoration or dosing advice. exposure: 480 versus 930 mg/day; recommended folate intake cross_nutrient: Choline modifies a folate-genotype-associated phenotype. [ganz-2016] Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis (2016). https://pubmed.ncbi.nlm.nih.gov/27342765/ DOI: 10.1096/fj.201500138rr
Complete structured claim and evidence
What acts on it
CHT1 supports reutilization of choline liberated by synaptic acetylcholine hydrolysis, sustaining presynaptic acetylcholine synthesis.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/38589607.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3cf951acec5056180aacccf73a96951c54fa40be5446cd778bd90eb23b43fd3a", "start_char": 0, "end_char": 1090, "text_sha256": "3cf951acec5056180aacccf73a96951c54fa40be5446cd778bd90eb23b43fd3a"}
- experimental_model
- Human CHT1 cryo-EM and functional characterization
- exposure
- Choline-bound, inhibitor-bound and apo conformations
- limitations
- Structural transport cycle; no claim of cognitive benefit from increasing intake.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human CHT1 protein
- plain_language
- After acetylcholine is broken down, choline can be taken back up and reused.
- primary_references
- [choline-p38589607] Transport mechanism of presynaptic high-affinity choline uptake by CHT1. (2024). https://pubmed.ncbi.nlm.nih.gov/38589607/ DOI: 10.1038/s41594-024-01259-w
- tissue_or_cell_type
- Presynaptic uptake mechanism and experimental structures
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 334–345
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CHT1 cryo-EM and functional characterization · source_derived_draft · unverified_draft
### choline-cht1-recycling CHT1 supports reutilization of choline liberated by synaptic acetylcholine hydrolysis, sustaining presynaptic acetylcholine synthesis. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: After acetylcholine is broken down, choline can be taken back up and reused. organism: Human CHT1 protein tissue_or_cell_type: Presynaptic uptake mechanism and experimental structures experimental_model: Human CHT1 cryo-EM and functional characterization limitations: Structural transport cycle; no claim of cognitive benefit from increasing intake. exposure: Choline-bound, inhibitor-bound and apo conformations evidence_span: {"source_cache": "artifacts/choline-research/38589607.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "3cf951acec5056180aacccf73a96951c54fa40be5446cd778bd90eb23b43fd3a", "start_char": 0, "end_char": 1090, "text_sha256": "3cf951acec5056180aacccf73a96951c54fa40be5446cd778bd90eb23b43fd3a"} [choline-p38589607] Transport mechanism of presynaptic high-affinity choline uptake by CHT1. (2024). https://pubmed.ncbi.nlm.nih.gov/38589607/ DOI: 10.1038/s41594-024-01259-w
Complete structured claim and evidenceHuman FLVCR1 facilitated concentration-driven choline transport across the plasma membrane.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/38778100.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4", "start_char": 0, "end_char": 1367, "text_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4"}
- experimental_model
- Human transporter expression, uptake, cryo-EM and mutagenesis
- exposure
- Choline/ethanolamine substrate challenges and purified transporter structures
- limitations
- Concentration-driven transport in these preparations; not proof that a single transporter supplies every tissue. Historical heme assignments are not copied as established choline mechanisms.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human proteins in experimental systems
- plain_language
- FLVCR1 can move choline across the cell boundary.
- primary_references
- [choline-p38778100] Molecular mechanism of choline and ethanolamine transport in humans. (2024). https://pubmed.ncbi.nlm.nih.gov/38778100/ DOI: 10.1038/s41586-024-07444-7
- tissue_or_cell_type
- Plasma-membrane transport
- transport_effect
- depends Recorded as concentration-driven transport, so the net direction follows the gradient.
- transport_pool
- the cytosol across the plasma membrane Recorded as concentration-driven transport, so the net direction follows the gradient.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 217–228
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human transporter expression, uptake, cryo-EM and mutagenesis · source_derived_draft · unverified_draft
### choline-flvcr1-choline Human FLVCR1 facilitated concentration-driven choline transport across the plasma membrane. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: FLVCR1 can move choline across the cell boundary. organism: Human proteins in experimental systems tissue_or_cell_type: Plasma-membrane transport experimental_model: Human transporter expression, uptake, cryo-EM and mutagenesis limitations: Concentration-driven transport in these preparations; not proof that a single transporter supplies every tissue. Historical heme assignments are not copied as established choline mechanisms. exposure: Choline/ethanolamine substrate challenges and purified transporter structures evidence_span: {"source_cache": "artifacts/choline-research/38778100.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4", "start_char": 0, "end_char": 1367, "text_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4"} [choline-p38778100] Molecular mechanism of choline and ethanolamine transport in humans. (2024). https://pubmed.ncbi.nlm.nih.gov/38778100/ DOI: 10.1038/s41586-024-07444-7
Complete structured claim and evidenceHuman FLVCR2 facilitated concentration-driven choline transport across the plasma membrane.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/38778100.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4", "start_char": 0, "end_char": 1367, "text_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4"}
- experimental_model
- Human transporter expression, uptake, cryo-EM and mutagenesis
- exposure
- Choline/ethanolamine substrate challenges and purified transporter structures
- limitations
- Concentration-driven transport in these preparations; not proof that a single transporter supplies every tissue. Historical heme assignments are not copied as established choline mechanisms.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human proteins in experimental systems
- plain_language
- FLVCR2 can move choline across the cell boundary.
- primary_references
- [choline-p38778100] Molecular mechanism of choline and ethanolamine transport in humans. (2024). https://pubmed.ncbi.nlm.nih.gov/38778100/ DOI: 10.1038/s41586-024-07444-7
- tissue_or_cell_type
- Plasma-membrane transport
- transport_effect
- depends Recorded as concentration-driven transport, so the net direction follows the gradient.
- transport_pool
- the cytosol across the plasma membrane Recorded as concentration-driven transport, so the net direction follows the gradient.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 243–254
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human transporter expression, uptake, cryo-EM and mutagenesis · source_derived_draft · unverified_draft
### choline-flvcr2-choline Human FLVCR2 facilitated concentration-driven choline transport across the plasma membrane. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: FLVCR2 can move choline across the cell boundary. organism: Human proteins in experimental systems tissue_or_cell_type: Plasma-membrane transport experimental_model: Human transporter expression, uptake, cryo-EM and mutagenesis limitations: Concentration-driven transport in these preparations; not proof that a single transporter supplies every tissue. Historical heme assignments are not copied as established choline mechanisms. exposure: Choline/ethanolamine substrate challenges and purified transporter structures evidence_span: {"source_cache": "artifacts/choline-research/38778100.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4", "start_char": 0, "end_char": 1367, "text_sha256": "0c0c95f81ece7f339f1b92631ced5244c053d1b4a4cbfd9ef964ff0640b5aed4"} [choline-p38778100] Molecular mechanism of choline and ethanolamine transport in humans. (2024). https://pubmed.ncbi.nlm.nih.gov/38778100/ DOI: 10.1038/s41586-024-07444-7
Complete structured claim and evidenceFolate repletion returned depressed plasma choline-status measures to baseline or above in the low-choline feeding studies.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- Folate repletion modifies choline status.
- experimental_model
- Metabolic-unit depletion/repletion: 11 men, 10 women.
- exposure
- 2-6 weeks folic-acid repletion
- limitations
- Not evidence folate replaces dietary choline.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Restoring folate improved the choline markers.
- primary_references
- [jacob-1999] Folate nutriture alters choline status of women and men fed low choline diets (1999). https://pubmed.ncbi.nlm.nih.gov/10082779/ DOI: 10.1093/jn/129.3.712
- tissue_or_cell_type
- Plasma
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 718–729
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolic-unit depletion/repletion: 11 men, 10 women. · source_derived_draft · unverified_draft
### folate-methyl-folate-choline-repletion Folate repletion returned depressed plasma choline-status measures to baseline or above in the low-choline feeding studies. Condition category: nutrient_deficiency nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Restoring folate improved the choline markers. organism: Homo sapiens tissue_or_cell_type: Plasma experimental_model: Metabolic-unit depletion/repletion: 11 men, 10 women. limitations: Not evidence folate replaces dietary choline. exposure: 2-6 weeks folic-acid repletion cross_nutrient: Folate repletion modifies choline status. [jacob-1999] Folate nutriture alters choline status of women and men fed low choline diets (1999). https://pubmed.ncbi.nlm.nih.gov/10082779/ DOI: 10.1093/jn/129.3.712
Complete structured claim and evidenceCombined low-folate/low-choline feeding lowered plasma choline by 28% in men and 25% in women.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- Folate and choline status are coupled.
- experimental_model
- Metabolic-unit depletion/repletion: 11 men, 10 women.
- exposure
- Men: 25 micrograms folate/238 mg choline daily; women: 56 micrograms/147 mg
- limitations
- No functional choline deficiency by measured transaminase/lipid endpoints.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Folate restriction strained choline markers during low choline intake.
- primary_references
- [jacob-1999] Folate nutriture alters choline status of women and men fed low choline diets (1999). https://pubmed.ncbi.nlm.nih.gov/10082779/ DOI: 10.1093/jn/129.3.712
- tissue_or_cell_type
- Plasma
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 693–704
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Metabolic-unit depletion/repletion: 11 men, 10 women. · source_derived_draft · unverified_draft
### folate-methyl-low-folate-choline Combined low-folate/low-choline feeding lowered plasma choline by 28% in men and 25% in women. Condition category: nutrient_deficiency nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Folate restriction strained choline markers during low choline intake. organism: Homo sapiens tissue_or_cell_type: Plasma experimental_model: Metabolic-unit depletion/repletion: 11 men, 10 women. limitations: No functional choline deficiency by measured transaminase/lipid endpoints. exposure: Men: 25 micrograms folate/238 mg choline daily; women: 56 micrograms/147 mg cross_nutrient: Folate and choline status are coupled. [jacob-1999] Folate nutriture alters choline status of women and men fed low choline diets (1999). https://pubmed.ncbi.nlm.nih.gov/10082779/ DOI: 10.1093/jn/129.3.712
Complete structured claim and evidence
Where it participates (unsigned role)
ChAT catalyzes reversible acetylcholine synthesis from choline and acetyl-CoA.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/11172068.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "691b96b9c5c149c554b99d8e1532ffee25084a8970f8deb23f0991dfd6013d39", "start_char": 0, "end_char": 1231, "text_sha256": "691b96b9c5c149c554b99d8e1532ffee25084a8970f8deb23f0991dfd6013d39"}
- experimental_model
- Human CHAT genetics, recombinant expression and enzyme kinetics
- exposure
- Ten recessive variants in five patients; nine mutant proteins assayed
- limitations
- Inherited enzyme defects, not a dietary choline-deficiency model. Acetyl-CoA and choline are distinct substrates.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human CHAT proteins; COS-cell and bacterial expression systems
- plain_language
- The neurotransmitter needs both the choline headgroup and an acetyl group supplied by acetyl-CoA.
- primary_references
- [choline-p11172068] Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. (2001). https://pubmed.ncbi.nlm.nih.gov/11172068/ DOI: 10.1073/pnas.98.4.2017
- tissue_or_cell_type
- Neuromuscular acetylcholine resynthesis
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 412–423
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CHAT genetics, recombinant expression and enzyme kinetics · source_derived_draft · unverified_draft
### choline-chat-acetylcholine ChAT catalyzes reversible acetylcholine synthesis from choline and acetyl-CoA. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The neurotransmitter needs both the choline headgroup and an acetyl group supplied by acetyl-CoA. organism: Human CHAT proteins; COS-cell and bacterial expression systems tissue_or_cell_type: Neuromuscular acetylcholine resynthesis experimental_model: Human CHAT genetics, recombinant expression and enzyme kinetics limitations: Inherited enzyme defects, not a dietary choline-deficiency model. Acetyl-CoA and choline are distinct substrates. exposure: Ten recessive variants in five patients; nine mutant proteins assayed evidence_span: {"source_cache": "artifacts/choline-research/11172068.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "691b96b9c5c149c554b99d8e1532ffee25084a8970f8deb23f0991dfd6013d39", "start_char": 0, "end_char": 1231, "text_sha256": "691b96b9c5c149c554b99d8e1532ffee25084a8970f8deb23f0991dfd6013d39"} [choline-p11172068] Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. (2001). https://pubmed.ncbi.nlm.nih.gov/11172068/ DOI: 10.1073/pnas.98.4.2017
Complete structured claim and evidenceThe pathway model identifies CHDH-mediated oxidation of choline to betaine aldehyde upstream of aldehyde-dehydrogenase-mediated betaine production.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/39111307.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "086a515ebf324a03baeb82e7fe21771eb7f819da09ef7a22372e06db25d3c571", "start_char": 3335, "end_char": 3656, "text_sha256": "580d72b54dac50ca5d1cfdb4e2ffe3719e957af76ac81d761422471424636d69"}
- experimental_model
- Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing
- exposure
- Biochemical pathway described in the study introduction
- limitations
- Established pathway background in this carrier study, not a newly isolated human CHDH catalytic assay. No cofactor identity or exclusive downstream ALDH isoform is inferred.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Mammalian pathway background applied to the human-cell arm
- plain_language
- Choline oxidation has an aldehyde intermediate; it is not one undifferentiated jump to betaine.
- primary_references
- [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
- tissue_or_cell_type
- Mitochondrial choline metabolism
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 464–475
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing · source_derived_draft · unverified_draft
### choline-chdh-aldehyde-step The pathway model identifies CHDH-mediated oxidation of choline to betaine aldehyde upstream of aldehyde-dehydrogenase-mediated betaine production. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Choline oxidation has an aldehyde intermediate; it is not one undifferentiated jump to betaine. organism: Mammalian pathway background applied to the human-cell arm tissue_or_cell_type: Mitochondrial choline metabolism experimental_model: Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing limitations: Established pathway background in this carrier study, not a newly isolated human CHDH catalytic assay. No cofactor identity or exclusive downstream ALDH isoform is inferred. exposure: Biochemical pathway described in the study introduction evidence_span: {"source_cache": "artifacts/choline-research/39111307.fulltext.txt", "locator": "Primary full-text span; zero-based, end-exclusive Unicode character offsets", "file_sha256": "086a515ebf324a03baeb82e7fe21771eb7f819da09ef7a22372e06db25d3c571", "start_char": 3335, "end_char": 3656, "text_sha256": "580d72b54dac50ca5d1cfdb4e2ffe3719e957af76ac81d761422471424636d69"} [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
Complete structured claim and evidenceHuman choline kinase alpha1 catalyzes ATP-dependent phosphorylation of choline, producing phosphocholine and ADP in magnesium-containing conditions.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/25515750.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "742dc604629df5eae2bb6cfc0ef0a13cbd69f5e318a2f3292e98f2e707958aeb", "start_char": 0, "end_char": 1321, "text_sha256": "742dc604629df5eae2bb6cfc0ef0a13cbd69f5e318a2f3292e98f2e707958aeb"}
- experimental_model
- Human choline kinase alpha1 and pathogen-enzyme biochemical comparison
- exposure
- ATP-dependent choline phosphorylation in magnesium-containing assays
- limitations
- The shared enzyme requirement is not a clinical magnesium threshold or proof of a general supplement rescue.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human alpha1 isoform; pathogen comparators remain separate
- plain_language
- Choline enters membrane synthesis through an ATP-powered phosphorylation step.
- primary_references
- [choline-p25515750] Choline kinase active site provides features for designing versatile inhibitors. (2014). https://pubmed.ncbi.nlm.nih.gov/25515750/ DOI: 10.2174/1568026614666141216093337
- tissue_or_cell_type
- Purified choline kinase active site
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 698–709
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human choline kinase alpha1 and pathogen-enzyme biochemical comparison · source_derived_draft · unverified_draft
### choline-chka-phosphocholine Human choline kinase alpha1 catalyzes ATP-dependent phosphorylation of choline, producing phosphocholine and ADP in magnesium-containing conditions. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Choline enters membrane synthesis through an ATP-powered phosphorylation step. organism: Human alpha1 isoform; pathogen comparators remain separate tissue_or_cell_type: Purified choline kinase active site experimental_model: Human choline kinase alpha1 and pathogen-enzyme biochemical comparison limitations: The shared enzyme requirement is not a clinical magnesium threshold or proof of a general supplement rescue. exposure: ATP-dependent choline phosphorylation in magnesium-containing assays evidence_span: {"source_cache": "artifacts/choline-research/25515750.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "742dc604629df5eae2bb6cfc0ef0a13cbd69f5e318a2f3292e98f2e707958aeb", "start_char": 0, "end_char": 1321, "text_sha256": "742dc604629df5eae2bb6cfc0ef0a13cbd69f5e318a2f3292e98f2e707958aeb"} [choline-p25515750] Choline kinase active site provides features for designing versatile inhibitors. (2014). https://pubmed.ncbi.nlm.nih.gov/25515750/ DOI: 10.2174/1568026614666141216093337
Complete structured claim and evidenceHuman CHT1-mediated choline uptake depended on Cl− in the oocyte assay.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"}
- experimental_model
- Human CHT1 expression in Xenopus oocytes
- exposure
- Choline, sodium and chloride titrations; hemicholinium-3 inhibition
- limitations
- Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human transporter; Xenopus oocyte host
- plain_language
- Cl− was part of the transport requirement, not just a background nutrient.
- primary_references
- [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
- tissue_or_cell_type
- Plasma-membrane transport assay
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 308–319
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CHT1 expression in Xenopus oocytes · source_derived_draft · unverified_draft
### choline-cht1-chloride Human CHT1-mediated choline uptake depended on Cl− in the oocyte assay. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Cl− was part of the transport requirement, not just a background nutrient. organism: Human transporter; Xenopus oocyte host tissue_or_cell_type: Plasma-membrane transport assay experimental_model: Human CHT1 expression in Xenopus oocytes limitations: Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry. exposure: Choline, sodium and chloride titrations; hemicholinium-3 inhibition evidence_span: {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"} [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
Complete structured claim and evidenceHuman CHT1-mediated choline uptake depended on Na+ in the oocyte assay.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"}
- experimental_model
- Human CHT1 expression in Xenopus oocytes
- exposure
- Choline, sodium and chloride titrations; hemicholinium-3 inhibition
- limitations
- Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human transporter; Xenopus oocyte host
- plain_language
- Na+ was part of the transport requirement, not just a background nutrient.
- primary_references
- [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
- tissue_or_cell_type
- Plasma-membrane transport assay
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 295–306
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CHT1 expression in Xenopus oocytes · source_derived_draft · unverified_draft
### choline-cht1-sodium Human CHT1-mediated choline uptake depended on Na+ in the oocyte assay. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Na+ was part of the transport requirement, not just a background nutrient. organism: Human transporter; Xenopus oocyte host tissue_or_cell_type: Plasma-membrane transport assay experimental_model: Human CHT1 expression in Xenopus oocytes limitations: Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry. exposure: Choline, sodium and chloride titrations; hemicholinium-3 inhibition evidence_span: {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"} [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
Complete structured claim and evidenceHuman CHT1 expression produced high-affinity choline uptake in Xenopus oocytes.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"}
- experimental_model
- Human CHT1 expression in Xenopus oocytes
- exposure
- Choline, sodium and chloride titrations; hemicholinium-3 inhibition
- limitations
- Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human transporter; Xenopus oocyte host
- plain_language
- This transporter supplies choline for the neuronal recycling route.
- primary_references
- [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
- tissue_or_cell_type
- Plasma-membrane transport assay
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 282–293
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Human CHT1 expression in Xenopus oocytes · source_derived_draft · unverified_draft
### choline-cht1-uptake Human CHT1 expression produced high-affinity choline uptake in Xenopus oocytes. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: This transporter supplies choline for the neuronal recycling route. organism: Human transporter; Xenopus oocyte host tissue_or_cell_type: Plasma-membrane transport assay experimental_model: Human CHT1 expression in Xenopus oocytes limitations: Assay EC50 values and Hill coefficients are not dietary requirements or exact ion-coupling stoichiometry. exposure: Choline, sodium and chloride titrations; hemicholinium-3 inhibition evidence_span: {"source_cache": "artifacts/choline-research/11068039.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5", "start_char": 0, "end_char": 1088, "text_sha256": "f9885c7f9525456b2c9eac0865a1f86cda2cf8f26cd6a8e34c212218f3a22bd5"} [choline-p11068039] Functional characterization of the human high-affinity choline transporter. (2000). https://pubmed.ncbi.nlm.nih.gov/11068039/ DOI: 10.1016/s0014-5793(00)02134-7
Complete structured claim and evidenceThe characterized anaerobic choline-utilization pathway uses a glycyl-radical choline TMA-lyase to cleave the choline C–N bond and generate TMA.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/23151509.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "20246eb796db8ca7b3ff78f530e744bd8f3abe8beb617358b0a1a924166fb2d6", "start_char": 0, "end_char": 1160, "text_sha256": "20246eb796db8ca7b3ff78f530e744bd8f3abe8beb617358b0a1a924166fb2d6"}
- experimental_model
- Anaerobic bacterial genetics, heterologous expression and EPR
- exposure
- Genetic knockout and heterologous expression of choline-utilization genes
- limitations
- A bacterial enzyme pathway, not a direct human-enzyme reaction or evidence that every microbiome produces the same TMA amount.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Desulfovibrio desulfuricans; E. coli expression host
- plain_language
- Gut microbial machinery can divert choline into a different metabolic route.
- primary_references
- [choline-p23151509] Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. (2012). https://pubmed.ncbi.nlm.nih.gov/23151509/ DOI: 10.1073/pnas.1215689109
- tissue_or_cell_type
- Microbial choline-utilization pathway
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 1101–1112
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Anaerobic bacterial genetics, heterologous expression and EPR · source_derived_draft · unverified_draft
### choline-cutc-tma The characterized anaerobic choline-utilization pathway uses a glycyl-radical choline TMA-lyase to cleave the choline C–N bond and generate TMA. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Gut microbial machinery can divert choline into a different metabolic route. organism: Desulfovibrio desulfuricans; E. coli expression host tissue_or_cell_type: Microbial choline-utilization pathway experimental_model: Anaerobic bacterial genetics, heterologous expression and EPR limitations: A bacterial enzyme pathway, not a direct human-enzyme reaction or evidence that every microbiome produces the same TMA amount. exposure: Genetic knockout and heterologous expression of choline-utilization genes evidence_span: {"source_cache": "artifacts/choline-research/23151509.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "20246eb796db8ca7b3ff78f530e744bd8f3abe8beb617358b0a1a924166fb2d6", "start_char": 0, "end_char": 1160, "text_sha256": "20246eb796db8ca7b3ff78f530e744bd8f3abe8beb617358b0a1a924166fb2d6"} [choline-p23151509] Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. (2012). https://pubmed.ncbi.nlm.nih.gov/23151509/ DOI: 10.1073/pnas.1215689109
Complete structured claim and evidenceParticipants who developed organ dysfunction recovered normal organ function after incremental choline repletion.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/choline-research/17490963.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28d18f06c2deb6f384ef2b5e84238b05deb076778619c21ee9682d49e34ae824", "start_char": 0, "end_char": 1758, "text_sha256": "28d18f06c2deb6f384ef2b5e84238b05deb076778619c21ee9682d49e34ae824"}
- experimental_model
- Controlled depletion/repletion with randomized folic acid supplementation
- exposure
- 550 mg choline/70 kg/day for 10 days, then less than 50 mg/70 kg/day up to 42 days; graded repletion
- limitations
- Supervised experimental depletion, not a recommended intake protocol. Liver/muscle endpoints and susceptibility differed; one cohort underlies related genetic publications.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human
- plain_language
- The experimentally induced signs were reversible with choline restoration.
- primary_references
- [choline-p17490963] Sex and menopausal status influence human dietary requirements for the nutrient choline. (2007). https://pubmed.ncbi.nlm.nih.gov/17490963/ DOI: 10.1093/ajcn/85.5.1275
- tissue_or_cell_type
- 57 adults: 26 men, 16 premenopausal and 15 postmenopausal women
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 1010–1021
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Controlled depletion/repletion with randomized folic acid supplementation · source_derived_draft · unverified_draft
### choline-depletion-recovery Participants who developed organ dysfunction recovered normal organ function after incremental choline repletion. Condition category: nutrient_deficiency nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: The experimentally induced signs were reversible with choline restoration. organism: Human tissue_or_cell_type: 57 adults: 26 men, 16 premenopausal and 15 postmenopausal women experimental_model: Controlled depletion/repletion with randomized folic acid supplementation limitations: Supervised experimental depletion, not a recommended intake protocol. Liver/muscle endpoints and susceptibility differed; one cohort underlies related genetic publications. exposure: 550 mg choline/70 kg/day for 10 days, then less than 50 mg/70 kg/day up to 42 days; graded repletion evidence_span: {"source_cache": "artifacts/choline-research/17490963.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "28d18f06c2deb6f384ef2b5e84238b05deb076778619c21ee9682d49e34ae824", "start_char": 0, "end_char": 1758, "text_sha256": "28d18f06c2deb6f384ef2b5e84238b05deb076778619c21ee9682d49e34ae824"} [choline-p17490963] Sex and menopausal status influence human dietary requirements for the nutrient choline. (2007). https://pubmed.ncbi.nlm.nih.gov/17490963/ DOI: 10.1093/ajcn/85.5.1275
Complete structured claim and evidenceThe in-vivo experiments identified Flvcr2 as a major route for blood-to-brain choline uptake.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/38693257.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "39822712c47b19d59930fdb695e57814c795431132b6d8118c619dad2e1566b3", "start_char": 0, "end_char": 1335, "text_sha256": "39822712c47b19d59930fdb695e57814c795431132b6d8118c619dad2e1566b3"}
- experimental_model
- BBB expression, mouse physiology and transporter structural analysis
- exposure
- Flvcr2 perturbation and choline uptake
- limitations
- The majority-contribution result is a model result, not a universal percentage in humans. This is free-choline transport, distinct from LPC-DHA transport.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Mouse in-vivo BBB experiments; construct-specific structural work
- plain_language
- Getting choline into the brain is a separate transport step from getting it into a neuron.
- primary_references
- [choline-p38693257] Structural and molecular basis of choline uptake into the brain by FLVCR2. (2024). https://pubmed.ncbi.nlm.nih.gov/38693257/ DOI: 10.1038/s41586-024-07326-y
- tissue_or_cell_type
- Blood-brain barrier endothelium
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 269–280
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · BBB expression, mouse physiology and transporter structural analysis · source_derived_draft · unverified_draft
### choline-flvcr2-brain The in-vivo experiments identified Flvcr2 as a major route for blood-to-brain choline uptake. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Getting choline into the brain is a separate transport step from getting it into a neuron. organism: Mouse in-vivo BBB experiments; construct-specific structural work tissue_or_cell_type: Blood-brain barrier endothelium experimental_model: BBB expression, mouse physiology and transporter structural analysis limitations: The majority-contribution result is a model result, not a universal percentage in humans. This is free-choline transport, distinct from LPC-DHA transport. exposure: Flvcr2 perturbation and choline uptake evidence_span: {"source_cache": "artifacts/choline-research/38693257.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "39822712c47b19d59930fdb695e57814c795431132b6d8118c619dad2e1566b3", "start_char": 0, "end_char": 1335, "text_sha256": "39822712c47b19d59930fdb695e57814c795431132b6d8118c619dad2e1566b3"} [choline-p38693257] Structural and molecular basis of choline uptake into the brain by FLVCR2. (2024). https://pubmed.ncbi.nlm.nih.gov/38693257/ DOI: 10.1038/s41586-024-07326-y
Complete structured claim and evidenceTwo weeks of phosphatidylcholine supplementation reduced fasting total homocysteine by 18% relative to placebo.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/16002808.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ad206000c96c52d280ac135c03d531122121a82c436dce40c7d13e55d0976ae1", "start_char": 0, "end_char": 1797, "text_sha256": "ad206000c96c52d280ac135c03d531122121a82c436dce40c7d13e55d0976ae1"}
- experimental_model
- Randomized crossover feeding trial
- exposure
- About 2.6 g choline/day as PC versus matched placebo oil for two weeks; methionine-load testing
- limitations
- High experimental intake and biomarker endpoint; no cardiovascular-event benefit was tested.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human
- plain_language
- A choline-containing form changed a methyl-metabolism blood marker.
- primary_references
- [choline-p16002808] Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. (2005). https://pubmed.ncbi.nlm.nih.gov/16002808/ DOI: 10.1093/ajcn.82.1.111
- tissue_or_cell_type
- 26 men with mildly elevated plasma homocysteine
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 1075–1086
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Randomized crossover feeding trial · source_derived_draft · unverified_draft
### choline-pc-hcy-fasting Two weeks of phosphatidylcholine supplementation reduced fasting total homocysteine by 18% relative to placebo. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A choline-containing form changed a methyl-metabolism blood marker. organism: Human tissue_or_cell_type: 26 men with mildly elevated plasma homocysteine experimental_model: Randomized crossover feeding trial limitations: High experimental intake and biomarker endpoint; no cardiovascular-event benefit was tested. exposure: About 2.6 g choline/day as PC versus matched placebo oil for two weeks; methionine-load testing evidence_span: {"source_cache": "artifacts/choline-research/16002808.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "ad206000c96c52d280ac135c03d531122121a82c436dce40c7d13e55d0976ae1", "start_char": 0, "end_char": 1797, "text_sha256": "ad206000c96c52d280ac135c03d531122121a82c436dce40c7d13e55d0976ae1"} [choline-p16002808] Choline supplemented as phosphatidylcholine decreases fasting and postmethionine-loading plasma homocysteine concentrations in healthy men. (2005). https://pubmed.ncbi.nlm.nih.gov/16002808/ DOI: 10.1093/ajcn.82.1.111
Complete structured claim and evidenceSLC25A48 loss impaired choline-derived betaine production in human-cell mitochondrial metabolism experiments.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_span
- {"source_cache": "artifacts/choline-research/39111307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f", "start_char": 0, "end_char": 1201, "text_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f"}
- experimental_model
- Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing
- exposure
- Germline mouse knockout; human-cell SLC25A48 loss; labeled choline
- limitations
- Transport, energy and one-carbon outcomes are model-specific; normal intake cannot be assumed to correct a carrier defect.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human HEK293T cells
- plain_language
- A transport defect can restrict methyl-donor production upstream of betaine.
- primary_references
- [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
- tissue_or_cell_type
- Brown adipose tissue and human HEK293T cells
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 490–501
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing · source_derived_draft · unverified_draft
### choline-slc25a48-betaine SLC25A48 loss impaired choline-derived betaine production in human-cell mitochondrial metabolism experiments. Condition category: machinery_impairment nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: A transport defect can restrict methyl-donor production upstream of betaine. organism: Human HEK293T cells tissue_or_cell_type: Brown adipose tissue and human HEK293T cells experimental_model: Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing limitations: Transport, energy and one-carbon outcomes are model-specific; normal intake cannot be assumed to correct a carrier defect. exposure: Germline mouse knockout; human-cell SLC25A48 loss; labeled choline evidence_span: {"source_cache": "artifacts/choline-research/39111307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f", "start_char": 0, "end_char": 1201, "text_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f"} [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
Complete structured claim and evidenceHuman-cell experiments identified SLC25A48 as necessary for efficient mitochondrial choline import.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/choline-research/39111307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f", "start_char": 0, "end_char": 1201, "text_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f"}
- experimental_model
- Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing
- exposure
- Germline mouse knockout; human-cell SLC25A48 loss; labeled choline
- limitations
- Transport, energy and one-carbon outcomes are model-specific; normal intake cannot be assumed to correct a carrier defect.
- nutrient_topic
- Choline research collection; topical membership is not evidence of a direct dietary effect. · Choline
- organism
- Human HEK293T cells
- plain_language
- Choline must cross another membrane to reach its mitochondrial metabolic route.
- primary_references
- [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
- tissue_or_cell_type
- Brown adipose tissue and human HEK293T cells
Choline: metabolism, signaling and nutrient connections (2026-09-17) · lines 477–488
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing · source_derived_draft · unverified_draft
### choline-slc25a48-import Human-cell experiments identified SLC25A48 as necessary for efficient mitochondrial choline import. Condition category: normal nutrient_topic: Choline research collection; topical membership is not evidence of a direct dietary effect. plain_language: Choline must cross another membrane to reach its mitochondrial metabolic route. organism: Human HEK293T cells tissue_or_cell_type: Brown adipose tissue and human HEK293T cells experimental_model: Slc25a48 knockout, rescue, mitochondrial assays and isotope tracing limitations: Transport, energy and one-carbon outcomes are model-specific; normal intake cannot be assumed to correct a carrier defect. exposure: Germline mouse knockout; human-cell SLC25A48 loss; labeled choline evidence_span: {"source_cache": "artifacts/choline-research/39111307.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f", "start_char": 0, "end_char": 1201, "text_sha256": "c0a9377732782bdaa55105cae0a0446afcfb1225e686d2b047a7fdf1ef67535f"} [choline-p39111307] SLC25A48 controls mitochondrial choline import and metabolism. (2024). https://pubmed.ncbi.nlm.nih.gov/39111307/ DOI: 10.1016/j.cmet.2024.07.010
Complete structured claim and evidenceUrinary recovery was approximately 43% for orthosilicic acid, 17% for choline-stabilized acid and 1% for colloidal silica in this comparison.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Small crossover comparisons; colloidal silica n=3, other sources at least five.
- limitations
- Different preparations and dissolution; not proof that choline itself suppresses absorption or defines a cofactor.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- The same elemental amount need not deliver the same soluble exposure.
- primary_references
- The comparative absorption of silicon from different foods and food supplements. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19356271/ · DOI 10.1017/S0007114509311757
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 80–86
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Small crossover comparisons; colloidal silica n=3, other sources at least five. · source_derived_draft · unverified_draft
## silica-formulation-absorption The same elemental amount need not deliver the same soluble exposure. Urinary recovery was approximately 43% for orthosilicic acid, 17% for choline-stabilized acid and 1% for colloidal silica in this comparison. Model: Small crossover comparisons; colloidal silica n=3, other sources at least five. Limitations: Different preparations and dissolution; not proof that choline itself suppresses absorption or defines a cofactor. Evidence access: Primary abstract The comparative absorption of silicon from different foods and food supplements. · 2009 · https://pubmed.ncbi.nlm.nih.gov/19356271/ · DOI 10.1017/S0007114509311757
Complete structured claim and evidencePINP differed from placebo at 12 months in the 6- and 12-mg Si groups without a clear dose response.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- 184 women randomized; 136 completed; all received 1,000 mg calcium and 20 micrograms D3 daily.
- limitations
- Marker result is not fracture prevention; attrition and multiple endpoints matter.
- nutrient_topic
- Silica collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Silica and soluble silicon
- plain_language
- A collagen-formation marker changed on top of calcium and vitamin D.
- primary_references
- Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18547426/ · DOI 10.1186/1471-2474-9-85
Silica: soluble silicon, cellular transport and particle-specific mechanisms (2026-09-19) · lines 376–382
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · 184 women randomized; 136 completed; all received 1,000 mg calcium and 20 micrograms D3 daily. · source_derived_draft · unverified_draft
## silica-human-pinp A collagen-formation marker changed on top of calcium and vitamin D. PINP differed from placebo at 12 months in the 6- and 12-mg Si groups without a clear dose response. Model: 184 women randomized; 136 completed; all received 1,000 mg calcium and 20 micrograms D3 daily. Limitations: Marker result is not fracture prevention; attrition and multiple endpoints matter. Evidence access: Primary abstract Choline-stabilized orthosilicic acid supplementation as an adjunct to calcium/vitamin D3 stimulates markers of bone formation in osteopenic females: a randomized, placebo-controlled trial. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18547426/ · DOI 10.1186/1471-2474-9-85
Complete structured claim and evidenceDespite SAH accumulation, the index case showed leukocyte DNA hypermethylation, along with low plasma choline/phosphatidylcholine and high guanidinoacetate.
Experimental context and source evidence
- availability_state
- biomarker_context Imported condition classification; unverified.
- evidence_access
- Primary abstract
- experimental_model
- Human AHCY-deficiency case; different tissues and biochemical readouts.
- limitations
- No universal high-SAH-to-all-DNA-hypomethylation rule is inferred.
- nutrient_topic
- L-Methionine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · L-Methionine
- plain_language
- A blood metabolite pattern does not predict every methylation endpoint in one direction.
- primary_references
- S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15024124/ · DOI 10.1073/pnas.0400658101
- trigger_kind
- biomarker_context Imported condition classification; unverified.
L-Methionine: transport, methylation, sulfur metabolism and cross-nutrient mechanisms (2026-09-19) · lines 188–194
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Human AHCY-deficiency case; different tissues and biochemical readouts. · source_derived_draft · unverified_draft
## methionine-ahcy-methylation-boundary A blood metabolite pattern does not predict every methylation endpoint in one direction. Despite SAH accumulation, the index case showed leukocyte DNA hypermethylation, along with low plasma choline/phosphatidylcholine and high guanidinoacetate. Model: Human AHCY-deficiency case; different tissues and biochemical readouts. Limitations: No universal high-SAH-to-all-DNA-hypomethylation rule is inferred. Evidence access: Primary abstract S-adenosylhomocysteine hydrolase deficiency in a human: a genetic disorder of methionine metabolism. · 2004 · https://pubmed.ncbi.nlm.nih.gov/15024124/ · DOI 10.1073/pnas.0400658101
Complete structured claim and evidenceHuman PHOSPHO1 also hydrolyzes phosphocholine, producing inorganic phosphate and choline.
Experimental context and source evidence
- experimental_model
- Purified-enzyme substrate assay
- limitations
- This reaction uses magnesium-dependent machinery; calcium is the eventual mineral constituent, not the demonstrated phosphatase cofactor.
- nutrient_topic
- Calcium research collection; topical membership is not evidence of a direct dietary effect. · Calcium
- organism
- Homo sapiens
- plain_language
- A second phospholipid-headgroup metabolite can supply phosphate.
- primary_references
- [roberts2004] Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities (2004). https://pubmed.ncbi.nlm.nih.gov/15175005/ DOI: 10.1042/BJ20040511
- tissue_or_cell_type
- Recombinant enzyme
Calcium: mechanism-first literature curation (2026-09-17) · lines 908–917
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Purified-enzyme substrate assay · source_derived_draft · unverified_draft
### phospho1-phosphocholine-hydrolysis Human PHOSPHO1 also hydrolyzes phosphocholine, producing inorganic phosphate and choline. Condition category: normal nutrient_topic: Calcium research collection; topical membership is not evidence of a direct dietary effect. plain_language: A second phospholipid-headgroup metabolite can supply phosphate. organism: Homo sapiens tissue_or_cell_type: Recombinant enzyme experimental_model: Purified-enzyme substrate assay limitations: This reaction uses magnesium-dependent machinery; calcium is the eventual mineral constituent, not the demonstrated phosphatase cofactor. [roberts2004] Human PHOSPHO1 exhibits high specific phosphoethanolamine and phosphocholine phosphatase activities (2004). https://pubmed.ncbi.nlm.nih.gov/15175005/ DOI: 10.1042/BJ20040511
Complete structured claim and evidenceThe potassium-induced increment in glucose-derived carbon-14 acetylcholine was 75% lower in deficient rat brain slices.
Experimental context and source evidence
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- cross_nutrient
- Links thiamine-dependent carbon metabolism with synthesis of a choline-containing transmitter; no choline repletion outcome was tested.
- evidence_location
- Abstract
- evidence_span
- declined by 50 and 75%, respectively
- experimental_model
- Symptomatic pyrithiamine-induced thiamine-deficient rats; brain slices assayed with uniformly carbon-14-labeled glucose at rest and during potassium stimulation; seven-day thiamine reversal arm.
- exposure
- Pyrithiamine-induced deficiency followed by potassium stimulation of rat brain slices
- limitations
- This tracer experiment did not test choline deficiency or choline supplementation; synthesis labeling is not transmitter release.
- nutrient_topic
- Thiamine research collection; topical membership is not evidence of a direct dietary effect. · Thiamine (vitamin B1)
- organism
- Rattus norvegicus
- plain_language
- Thiamine disruption limited stimulated production of the choline-containing transmitter from glucose-derived carbon.
- primary_references
- [gibson-1984-brain-flux] Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal (1984). https://pubmed.ncbi.nlm.nih.gov/6149477/ DOI: 10.1007/BF00965667
- tissue_or_cell_type
- Brain slices
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
Thiamine: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 1112–1125
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Symptomatic pyrithiamine-induced thiamine-deficient rats; brain slices assayed with uniformly carbon-14-labeled glucose at rest and during potassium stimulation; seven-day thiamine reversal arm. · source_derived_draft · unverified_draft
### thiamine-def-stimulated-acetylcholine-synthesis The potassium-induced increment in glucose-derived carbon-14 acetylcholine was 75% lower in deficient rat brain slices. Condition category: nutrient_deficiency nutrient_topic: Thiamine research collection; topical membership is not evidence of a direct dietary effect. plain_language: Thiamine disruption limited stimulated production of the choline-containing transmitter from glucose-derived carbon. organism: Rattus norvegicus tissue_or_cell_type: Brain slices experimental_model: Symptomatic pyrithiamine-induced thiamine-deficient rats; brain slices assayed with uniformly carbon-14-labeled glucose at rest and during potassium stimulation; seven-day thiamine reversal arm. limitations: This tracer experiment did not test choline deficiency or choline supplementation; synthesis labeling is not transmitter release. evidence_location: Abstract evidence_span: declined by 50 and 75%, respectively cross_nutrient: Links thiamine-dependent carbon metabolism with synthesis of a choline-containing transmitter; no choline repletion outcome was tested. exposure: Pyrithiamine-induced deficiency followed by potassium stimulation of rat brain slices [gibson-1984-brain-flux] Correlation of enzymatic, metabolic, and behavioral deficits in thiamin deficiency and its reversal (1984). https://pubmed.ncbi.nlm.nih.gov/6149477/ DOI: 10.1007/BF00965667
Complete structured claim and evidenceMouse hippocampal alpha7 currents remained insensitive to kynurenic acid, including slices prepared and stored in 1 mM for over 90 minutes, although glutamatergic currents were blocked.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse hilar and stratum-radiatum interneuron recordings.
- limitations
- Does not mean kynurenic acid has no neural effects.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- The negative receptor result persisted with prolonged high exposure and a positive pharmacological control.
- primary_references
- Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22848433/ · DOI 10.1371/journal.pone.0041108
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 306–312
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Mouse hilar and stratum-radiatum interneuron recordings. · source_derived_draft · unverified_draft
## tryptophan-kyna-alpha7-mouse-null The negative receptor result persisted with prolonged high exposure and a positive pharmacological control. Mouse hippocampal alpha7 currents remained insensitive to kynurenic acid, including slices prepared and stored in 1 mM for over 90 minutes, although glutamatergic currents were blocked. Model: Mouse hilar and stratum-radiatum interneuron recordings. Limitations: Does not mean kynurenic acid has no neural effects. Evidence access: Primary abstract Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22848433/ · DOI 10.1371/journal.pone.0041108
Complete structured claim and evidenceKynurenic acid did not inhibit choline-evoked alpha7 currents in rat hippocampal slice interneurons, contrasting with earlier reports.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Adolescent rat stratum-radiatum interneurons in acute slices.
- limitations
- Slice age, temperature, agonist delivery and receptor environment are candidate explanations, not a demonstrated resolution.
- nutrient_topic
- Tryptophan collection; molecular form, preparation, species, exposure and manipulation remain explicit. · L-Tryptophan
- plain_language
- Another experiment did not reproduce the claimed receptor block.
- primary_references
- Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22848433/ · DOI 10.1371/journal.pone.0041108
Tryptophan: transport, protein synthesis, neuroactive metabolites, NAD and microbial pathways (2026-09-19) · lines 298–304
AI-assisted research curation; primary-abstract references and experimental limitations individually identified. Not publisher full text. · supports · Adolescent rat stratum-radiatum interneurons in acute slices. · source_derived_draft · unverified_draft
## tryptophan-kyna-alpha7-rat-null Another experiment did not reproduce the claimed receptor block. Kynurenic acid did not inhibit choline-evoked alpha7 currents in rat hippocampal slice interneurons, contrasting with earlier reports. Model: Adolescent rat stratum-radiatum interneurons in acute slices. Limitations: Slice age, temperature, agonist delivery and receptor environment are candidate explanations, not a demonstrated resolution. Evidence access: Primary abstract Lack of modulation of nicotinic acetylcholine alpha-7 receptor currents by kynurenic acid in adult hippocampal interneurons. · 2012 · https://pubmed.ncbi.nlm.nih.gov/22848433/ · DOI 10.1371/journal.pone.0041108
Complete structured claim and evidenceBerberine inhibited choline-to-TMA conversion in bacterial cultures and gut consortia, including human fecal samples.
Experimental context and source evidence
- evidence_span
- {"source_cache": "artifacts/berberine-research/33863898.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a81ea95bbf1d7f7f1e924998b9e02bc29d908d759dd575ffdf9c56bf4deb9b77", "start_char": 0, "end_char": 1309, "text_sha256": "a81ea95bbf1d7f7f1e924998b9e02bc29d908d759dd575ffdf9c56bf4deb9b77"}
- experimental_model
- Choline tracer, microbial culture, microbiome transfer and atherosclerosis models
- exposure
- Choline-supplemented chow and berberine; deuterated choline tracing
- limitations
- Human fecal culture is not a human treatment trial. Reduced TMAO in mice does not establish fewer human cardiovascular events or justify reducing essential choline intake.
- nutrient_topic
- Berberine research collection; topical membership is not evidence of a direct dietary effect. · Berberine
- organism
- C57BL/6J and ApoE-knockout mice; bacterial cultures and human fecal consortia
- plain_language
- The nutrient choline has a microbial metabolic branch that berberine can influence.
- primary_references
- [berberine-p33863898] Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. (2021). https://pubmed.ncbi.nlm.nih.gov/33863898/ DOI: 10.1038/s41522-021-00205-8
- tissue_or_cell_type
- Microbial choline metabolism
Berberine: metabolism, nutrient connections and drug interactions (2026-09-17) · lines 1078–1089
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Choline tracer, microbial culture, microbiome transfer and atherosclerosis models · source_derived_draft · unverified_draft
### berberine-choline-tma Berberine inhibited choline-to-TMA conversion in bacterial cultures and gut consortia, including human fecal samples. Condition category: normal nutrient_topic: Berberine research collection; topical membership is not evidence of a direct dietary effect. plain_language: The nutrient choline has a microbial metabolic branch that berberine can influence. organism: C57BL/6J and ApoE-knockout mice; bacterial cultures and human fecal consortia tissue_or_cell_type: Microbial choline metabolism experimental_model: Choline tracer, microbial culture, microbiome transfer and atherosclerosis models limitations: Human fecal culture is not a human treatment trial. Reduced TMAO in mice does not establish fewer human cardiovascular events or justify reducing essential choline intake. exposure: Choline-supplemented chow and berberine; deuterated choline tracing evidence_span: {"source_cache": "artifacts/berberine-research/33863898.abstract.txt", "locator": "Primary indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "a81ea95bbf1d7f7f1e924998b9e02bc29d908d759dd575ffdf9c56bf4deb9b77", "start_char": 0, "end_char": 1309, "text_sha256": "a81ea95bbf1d7f7f1e924998b9e02bc29d908d759dd575ffdf9c56bf4deb9b77"} [berberine-p33863898] Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. (2021). https://pubmed.ncbi.nlm.nih.gov/33863898/ DOI: 10.1038/s41522-021-00205-8
Complete structured claim and evidenceSAC in drinking water increased serum and hepatic GSH during methionine/choline-deficient feeding.
Experimental context and source evidence
- acting_entity
- s-allylcysteine
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- dose
- SAC 1 g/L drinking water
- duration
- Seven weeks
- evidence_access
- Primary abstract
- experimental_comparison
- SAC or S-ethylcysteine separately with deficient diet versus diet controls
- experimental_model
- Methionine/choline-deficient diet; liver and serum measurements
- interpretation_status
- Source-derived research curation; not independent primary verification
- limitations
- Does not establish replacement of methionine or choline, or direct donation of cysteine to GSH.
- nutrient_topic
- S-allylcysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · S-allyl-L-cysteine / SAC
- organism
- Mus musculus
- plain_language
- A nutrient-deficiency model connects SAC to glutathione status.
- primary_references
- [18786595] Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18786595/ · DOI 10.1016/j.fct.2008.08.010
- route
- Oral drinking water
- tissue_or_cell_type
- Methionine/choline-deficient diet; liver and serum measurements
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
S-allylcysteine: sulfur signaling, redox responses and cross-nutrient mechanisms (2026-09-20) · lines 365–372
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Methionine/choline-deficient diet; liver and serum measurements · source_derived_draft · unverified_draft
## s-allylcysteine-mcd-glutathione A nutrient-deficiency model connects SAC to glutathione status. SAC in drinking water increased serum and hepatic GSH during methionine/choline-deficient feeding. Model: Methionine/choline-deficient diet; liver and serum measurements Limitations: Does not establish replacement of methionine or choline, or direct donation of cysteine to GSH. Evidence access: Primary abstract [18786595] Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18786595/ · DOI 10.1016/j.fct.2008.08.010 Structured context: {"organism": "Mus musculus", "tissue_or_cell_type": "Methionine/choline-deficient diet; liver and serum measurements", "dose": "SAC 1 g/L drinking water", "duration": "Seven weeks", "route": "Oral drinking water", "experimental_comparison": "SAC or S-ethylcysteine separately with deficient diet versus diet controls", "acting_entity": "s-allylcysteine", "interpretation_status": "Source-derived research curation; not independent primary verification"}
Complete structured claim and evidenceSAC reduced hepatic G6PDH and FAS activities and triglyceride accumulation during the deficient diet.
Experimental context and source evidence
- acting_entity
- s-allylcysteine
- availability_state
- nutrient_deficiency Imported condition classification; unverified.
- dose
- SAC 1 g/L drinking water
- duration
- Seven weeks
- evidence_access
- Primary abstract
- experimental_comparison
- SAC or S-ethylcysteine separately with deficient diet versus diet controls
- experimental_model
- Methionine/choline-deficient diet; liver and serum measurements
- interpretation_status
- Source-derived research curation; not independent primary verification
- limitations
- Model-specific enzyme activities; not evidence of direct G6PDH binding or a universal NADPH effect.
- nutrient_topic
- S-allylcysteine collection; species, compartment, exposure, co-substrates and manipulation remain explicit. · S-allyl-L-cysteine / SAC
- organism
- Mus musculus
- plain_language
- The response involved lipid metabolism as well as redox markers.
- primary_references
- [18786595] Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18786595/ · DOI 10.1016/j.fct.2008.08.010
- route
- Oral drinking water
- tissue_or_cell_type
- Methionine/choline-deficient diet; liver and serum measurements
- trigger_kind
- nutrient_deficiency Imported condition classification; unverified.
S-allylcysteine: sulfur signaling, redox responses and cross-nutrient mechanisms (2026-09-20) · lines 374–381
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Methionine/choline-deficient diet; liver and serum measurements · source_derived_draft · unverified_draft
## s-allylcysteine-mcd-lipogenesis The response involved lipid metabolism as well as redox markers. SAC reduced hepatic G6PDH and FAS activities and triglyceride accumulation during the deficient diet. Model: Methionine/choline-deficient diet; liver and serum measurements Limitations: Model-specific enzyme activities; not evidence of direct G6PDH binding or a universal NADPH effect. Evidence access: Primary abstract [18786595] Alleviative effects of s-allyl cysteine and s-ethyl cysteine on MCD diet-induced hepatotoxicity in mice. · 2008 · https://pubmed.ncbi.nlm.nih.gov/18786595/ · DOI 10.1016/j.fct.2008.08.010 Structured context: {"organism": "Mus musculus", "tissue_or_cell_type": "Methionine/choline-deficient diet; liver and serum measurements", "dose": "SAC 1 g/L drinking water", "duration": "Seven weeks", "route": "Oral drinking water", "experimental_comparison": "SAC or S-ethylcysteine separately with deficient diet versus diet controls", "acting_entity": "s-allylcysteine", "interpretation_status": "Source-derived research curation; not independent primary verification"}
Complete structured claim and evidenceNonpregnant MTHFR rs1801133 carriers had lower labeled betaine:phosphatidylcholine enrichment ratios than noncarriers (0.8 versus 0.9).
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- cross_nutrient
- Folate-pathway genotype relates to choline allocation.
- experimental_model
- Choline feeding and isotope tracing in women across reproductive states.
- limitations
- Genotypes not randomized; ratio is a pathway proxy.
- nutrient_topic
- Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. · Folate (vitamin B9)
- organism
- Homo sapiens
- plain_language
- Relative choline allocation shifted toward phosphatidylcholine.
- primary_references
- [ganz-2016] Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis (2016). https://pubmed.ncbi.nlm.nih.gov/27342765/ DOI: 10.1096/fj.201500138rr
- tissue_or_cell_type
- Plasma tracer metabolites
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Folate and folic acid: mechanisms, deficiency and nutrient interactions (2026-09-17) · lines 731–741
AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Choline feeding and isotope tracing in women across reproductive states. · source_derived_draft · unverified_draft
### folate-methyl-variant-choline-allocation Nonpregnant MTHFR rs1801133 carriers had lower labeled betaine:phosphatidylcholine enrichment ratios than noncarriers (0.8 versus 0.9). Condition category: machinery_impairment nutrient_topic: Folate and folic acid research collection; topical membership is not evidence of a direct dietary effect. plain_language: Relative choline allocation shifted toward phosphatidylcholine. organism: Homo sapiens tissue_or_cell_type: Plasma tracer metabolites experimental_model: Choline feeding and isotope tracing in women across reproductive states. limitations: Genotypes not randomized; ratio is a pathway proxy. cross_nutrient: Folate-pathway genotype relates to choline allocation. [ganz-2016] Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis (2016). https://pubmed.ncbi.nlm.nih.gov/27342765/ DOI: 10.1096/fj.201500138rr
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.